United States Daptomycin Market Report: Growing Demand for Effective Therapies Against Resistant Gram-Positive Bacterial Infections
  The United States remains the largest contributor to the Daptomycin Market due to its robust pharmaceutical industry, extensive hospital network, and rising burden of antibiotic-resistant infections. Increasing cases of methicillin-resistant Staphylococcus aureus (MRSA) and other serious bacterial infections have fueled demand for advanced antibiotic treatments such as daptomycin. The...
0 Kommentare 0 Geteilt 45 Ansichten 0 Bewertungen